PharmaResources (Shanghai) Co., Ltd. (SHE:301230)
China flag China · Delayed Price · Currency is CNY
30.80
+0.02 (0.07%)
Sep 1, 2026, 4:00 PM EDT

SHE:301230 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
700.02688.35544.47489.72478.88448.21
Revenue Growth
10.86%26.43%11.18%2.26%6.84%58.38%
Gross Profit
182.51176.83130.58139.11174.42170.22
Operating Income
30.3922.55-8.926.6460.2586.98
Net Income
38.2634.2917.0837.6267.1873.58
Earnings Per Share
0.210.180.090.210.470.54
EPS Growth
43.05%100.00%-55.56%-55.57%-13.59%48.83%

Revenue by Segment

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Drug Discovery
396.98316.57293.21274.73234.89
Process Research and Development
63.7148.1677.8780.3192.83
Commercial Production
197.91165.21109.4117.09118.72
Unallocated Others
29.7614.529.246.761.77
Total
688.35544.47489.72478.88448.21

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
281.97312.58340.81550.05780.65113.17
Total Debt
144.4165.31181.71206.35100.3108.35
Net Cash (Debt)
137.56147.27159.11343.69680.354.82
Net Cash Growth
-15.66%-7.44%-53.71%-49.48%14005.50%-94.56%
Net Cash Per Share
0.740.790.861.904.730.04

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
168.1135.5180.8620.8699.29105.12
Capital Expenditures
-65.67-43.32-109.4-248.27-123.97-92.12
Free Cash Flow
102.4492.2-28.54-227.41-24.6713.01
Free Cash Flow Growth
167.63%-----37.90%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
26.07%25.69%23.98%28.41%36.42%37.98%
Operating Margin
4.34%3.28%-1.63%5.44%12.58%19.41%
Pretax Margin
5.11%4.11%0.65%7.51%15.23%19.24%
Profit Margin
5.47%4.98%3.14%7.68%14.03%16.42%
FCF Margin
14.63%13.39%-5.24%-46.44%-5.15%2.90%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23
Dividend Per Share
0.2850.2850.3310.1950.211
Dividend Per Share Growth
0%-13.97%69.47%-7.66%-
Dividend Yield
0.76%1.25%1.72%0.95%0.98%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
146.69119.80205.47102.4261.13-
Forward PE
89.0874.6752.6230.60--
P/FCF Ratio
52.6344.56----
PS Ratio
7.705.976.457.878.57-